Medicines & drugs recalls
909 recalls since January 2025 from Health Canada, FDA, newest first. Last notice 19 Nov 2026.
Page 6 of 19
- AbbVie Inc. recalls PRED MILDFDAFailed Stability Specifications
- Hybrid Infusions Ltd. recalls Champagne Supernova 3x0.5g Pre-Roll due to packaging and labelling issueHealth CanadaLabelling and packaging
- Hizentra: The appearance is out of specification in the affected lot.Health CanadaProduct quality
- Rubicon Holdings Corp. recalls one lot of Simply Bare Organics BC Organic Blue Dream Pre-Rolls due to packaging and labelling issueHealth CanadaLabelling and packaging
- Wisconsin Pharmacal Company recalls MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oa…FDAMicrobial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
- Lannett Company Inc. recalls Primidone Tablets USPFDACross contamination with other products: API contaminated with trace amounts of Acemetacin API.
- Lupin Pharmaceuticals Inc. recalls Liraglutide InjectionFDAPresence of particulate matter: a white thread-like structure in the cartridge
- Golden State Medical Supply Inc. recalls Primidone TabletsFDACross contamination with other products: API contaminated with trace amounts of Acemetacin API.
- Zydus Pharmaceuticals (USA) Inc recalls Erythromycin TabletsFDACGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
- Sagent Pharmaceuticals recalls Busulfan InjectionFDAFailed Impurities/Degradation Specifications
- Amerisource Health Services LLC recalls Primidone TabletsFDACross contamination with other products: API contaminated with trace amounts of Acemetacin API.
- Safecor Health, LLC recalls Atomoxetine Capsules HCLFDALabeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.
- Safecor Health, LLC recalls Vitamin B-ComplexFDAPresence of a Foreign Substance; black particles observed in liquid
- Haleon US Holdings LLC recalls Gas-XFDALabeling: Not Elsewhere Classified- Incomplete inactive ingredient information on the carton labeling.
- UCB Biosciences Inc. recalls cimzia (certolizumab pegol)FDALack of Assurance of Sterility
- ANI Pharmaceuticals, Inc. recalls Estradiol GelFDADefective Container; packets were found to be either empty or partially full.
- IntegraDose Compounding Services LLC recalls fentaNYL CitrateFDASubpotent Drug
- Kirkland Signature Women 50+ Multivitamin: may contain the presence of foreign matter (metal fragments)Health CanadaProduct quality
- CannaPiece Corp. recalls JAYs - Pink Pennifer 0.4g all-in-one vape due to labelling issueHealth CanadaLabelling and packaging
- Personnelle Supravite Energizing Formula: The breakage of vials can generate glass fragmentsHealth CanadaProduct quality
- ERYTHROMYCIN OPHTHALMIC OINTMENT USP: The sterility of the product could be compromised.Health CanadaProduct quality
- ENDO USA, Inc. recalls Buprenorphine HydrochlorideFDACrystallization; identified as Buprenorphine free base
- Ascend Laboratories, LLC recalls Ascend LaboratoriesFDAFailed Dissolution Specifications
- Oasis Medical, Inc. recalls Oasis Tears PFFDALack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent…
- Honibe Honey Gummies - Melatonin: Daily recommended intake may cause the active ingredient to exceed the allowable limit.Health CanadaProduct quality
- Unichem Pharmaceuticals USA Inc. recalls busPIRone Hydrochloride TabletsFDASubpotent drug
- Acella Pharmaceuticals, LLC recalls NAPROXEN ORAL SUSPENSIONFDAChemical contamination; presence of lead and lithium above specification
- Ajanta Pharma Ltd. recalls Duloxetine Delayed-Release CapsulesFDACGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month…
- CareFusion 213, LLC recalls BD PurPrepFDALack of assurance of Sterility: potential product contamination
- JB Chemicals and Pharmaceuticals Ltd recalls Enalapril Maleate TabletsFDAFailed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
- B BRAUN MEDICAL INC recalls Lactated Ringer's Injection USPFDAPresence of Particulate Matter.
- Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules USPFDACGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
- Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable SuspensionFDALack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
- Fresenius Medical Care Holdings, Inc. recalls DELFLEXFDALack of Assurance of Sterility: Potential leaks from perforations in bags.
- Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles recalls TPN bag (patient specific)FDAIncorrect Product Formulation: product did not contain insulin as listed in the label.
- Nitrous Oxide Chargers: Sold for Inhalation Without Market Authorization (DIN)Health CanadaUnauthorized product
- GHK-Cu & BPC-157 powder: Unauthorized active pharmaceutical ingredientsHealth CanadaProduct quality
- Wells Pharma of Houston LLC recalls Ketamine Hydrochloride Injectable Solution and 4 moreFDACGMP deviations.
- Water-Jel Technologies, LLC recalls Lidocaine Wound Gel (Benzalkonium ChlorideFDAFailed PH Specifications
- Hikma Pharmaceuticals USA INC recalls Alendronate Sodium Oral SolutionFDAThis recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
- American Regent, Inc. recalls Levocarnitine InjectionFDALabeling: Missing Label
- Thea Pharma, Inc. recalls Similasan and 1 moreFDALack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.
- SCOPE HEALTH recalls Optase Dry Eye Intense Drops (Glycerin 0.2%)FDALack of Assurance of Sterility
- Alcon Research LLC recalls GenTeal Tears and 1 moreFDALack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.
- PMS-BUSULFAN 6mg/mL: impurity could be out of specificationHealth CanadaProduct quality
- Leading Pharma, LLC recalls Furosemide TabletsFDACGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
- Hetero Labs Limited (Unit V) recalls Pantoprazole SodiumFDADiscoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
- B BRAUN MEDICAL INC recalls DEXTROSE INJECTION USP and 3 moreFDALack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
- Teva Pharmaceuticals USA, Inc recalls Claravis (isotretinoin capsuleFDAFailed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin
- The Harvard Drug Group LLC recalls Omega-3-AcidFDAFailed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.